SARS-CoV-2 variants from mink evade inhibition by antibodies

Por um escritor misterioso

Descrição

It has been known for about a year that minks can become infected with SARS-CoV-2. The virus had been transmitted from humans to farmed mink and mutated in infected animals. Mutations were acquired in the spike protein, which is crucial for the entry of the virus into host cells and represents the central point of attack for antibodies. These SARS-CoV-2 variants from mink were transmitted back to humans, raising concerns that minks could be a continuing source of infection of humans with SARS-CoV-2 variants with altered biological properties. Researchers at the German Primate Center (DPZ) - Leibniz Institute for Primate Research in Göttingen, Germany, have now shown that an antibody used for COVID-19 therapy is unable to effectively inhibit SARS-CoV-2 harboring a spike mutation acquired in minks. In addition, the mutation reduced the inhibition of the virus by antibodies produced in SARS-CoV-2 infected humans. These results show that SARS-CoV-2 can acquire mutations in minks that may reduce control of the virus by the human immune system. The study and findings have been published in Cell Reports.
SARS-CoV-2 variants from mink evade inhibition by antibodies
Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
SARS-CoV-2 variants from mink evade inhibition by antibodies
Frontiers The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2
SARS-CoV-2 variants from mink evade inhibition by antibodies
Frontiers SARS-COV-2 Variants: Differences and Potential of Immune Evasion
SARS-CoV-2 variants from mink evade inhibition by antibodies
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination - ScienceDirect
SARS-CoV-2 variants from mink evade inhibition by antibodies
COVID-19 - Wikipedia
SARS-CoV-2 variants from mink evade inhibition by antibodies
Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications
SARS-CoV-2 variants from mink evade inhibition by antibodies
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
SARS-CoV-2 variants from mink evade inhibition by antibodies
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
SARS-CoV-2 variants from mink evade inhibition by antibodies
The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice
de por adulto (o preço varia de acordo com o tamanho do grupo)